Clinical Trial: Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07282587) titled 'Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma' on Dec. 05.

Brief Summary: This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).

Study Start Date: Dec. 15

Study Type: INTERVENTIONAL

Condition: Advanced Pheochromocytoma and Paraganglioma PCPG

Intervention: DRUG: ONC206

150 mg BID TIW

DRUG: ONC206: Dose 1

DRUG: ONC206: Dose 2

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jazz Pharmaceuticals

Published by HT Digital Content Services with permission from Health Daily Digest....